TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/9/23 19:03 | 6/8/23 | KRYS | Krystal Biotech, Inc. | Health | BioPrd | Biological Products, (No Diag | Janney Daniel | PA | D | S.m | -6,418 | 128.36 | 0 | -50 | -32 | 107 | I | ||||||||||||||||
5/23/23 16:20 | 5/19/23 | KRYS | Krystal Biotech, Inc. | Health | BioPrd | Biological Products, (No Diag | Janney Daniel | PA | D | S | -4,751 | 95.02 | 0 | -50 | -24 | 157 | I | ||||||||||||||||
5/11/23 16:30 | 5/9/23 | KRYS | Krystal Biotech, Inc. | Health | BioPrd | Biological Products, (No Diag | Janney Daniel | PA | D | S | -1,552 | 90.74 | 0 | -17 | -8 | 207 | I | ||||||||||||||||
4/21/23 16:10 | 4/19/23 | KRYS | Krystal Biotech, Inc. | Health | BioPrd | Biological Products, (No Diag | Janney Daniel | PA | D | S | -713 | 90.32 | 0 | -8 | -3 | 224 | I | ||||||||||||||||
9/23/22 16:25 | 9/21/22 | ALLK | Allakos Inc. | DE | Health | Drug | Pharmaceutical Preparations | Janney Daniel | WY | DT | P | 2,385 | 5.02 | 0 | 475 | 6 | 9,050 | I | |||||||||||||||
12/14/21 16:11 | 12/10/21 | KRYS | Krystal Biotech, Inc. | Health | BioPrd | Biological Products, (No Diag | Janney Daniel | PA | D | S | -7,050 | 70.50 | 0 | -100 | -27 | 266 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |